Posted June 07, 2021
By Ray Blanco
What the New Alzheimer’s Drug Means for You
This morning, the FDA approved its first Alzheimer’s drug in nearly 20 years.
This is huge news for the biotech industry and shows that there’s hope for treating the disease.
With this news biotech across the board is up, but it’s not the only thing making moves.
Here’s what I’m looking at this week…
- Supersonic Flight Making a Comeback
Supersonic flight has a lot of problems.
Sonic booms shatter windows, cause noise pollution and generally disrupt communities.
It’s why we’ve never had supersonic commercial travel since the Concorde was grounded in 2003.
Now, though, United Airlines is looking to solve those issues.
- FDA Approves First Alzheimer’s Drug in 20 Years
For the first time in two decades, the FDA has approved a new Alzheimer’s drug.
Biogen’s aducanumab has proven to slow the cognitive decline of patients with Alzheimer’s.
And though it isn’t yet a cure for the disease itself…
- The Chip of the Future
Neuralink chips have been touted as the next step in brain biotech.
The applications are seemingly endless.
From bringing back motor functions to bringing back a person’s eyesight…
To even allowing a person to understand every language out there.
- Filling up at a Convenience Store?
7-Eleven announced that it would be adding EV charging stations to 250 of its locations by the end of 2022.
It follows the trend of EVs getting more and more mainstream.
But it also shows that anyone can get into the game.
That’s all for this week. There are a lot of exciting stories to follow and I’ll be looking at each of these sectors closely.
As always, shoot me an email at AskRay@StPaulResearch.com to let me know what you’re following!
To a bright future,
Chief Technology Expert, Technology Profits Daily